Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years

Thorax

Volumn 56, Issue 4, 2001, Pages 272-278

  Tattersfield, A E ^a   Town, G I ^b   Johnell, O ^c   Picado, C ^d   Aubier, M ^e   Braillon, P ^f   Karlstrom R ^g  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d HOSPITAL CLÍNIC   (Spain)

^e BICHAT HOSPITAL   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

^g ASTRAZENECA R AND D   (Sweden)

Author keywords

Asthma; Bone mineral density; Inhaled corticosteroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; HYDROCORTISONE; PREDNISOLONE;

ADULT; ARTICLE; ASTHMA; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG INDUCED DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FORCED EXPIRATORY VOLUME; HUMAN; LUMBAR SPINE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BONE DENSITY; BRONCHODILATOR AGENTS; BUDESONIDE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0035064750     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.4.272     Document Type: Article

References (22)

1. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
2. Efficacy and safety of inhaled corticosteroids in asthma
3. Asthma quality of life during one year of treatment with budesonide with or without formoterol
4. The British guidelines on asthma management: 1995 review and position statement
5. Inhaled corticosteroids: Benefits and risks
6. Corticosteroids and osteoporosis
7. The effect of inhaled corticosteroids on bone density in asthmatic patients
8. Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate
9. Bone mineral density changes in women taking inhaled corticosteroids
10. Effect of beclomethasone dipropionate on bone mineral content assessed by x-ray densitometry in asthmatic children: A longitudinal evaluation
11. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years
12. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density
13. Long-term influence of inhaled corticosteroids on bone metabolism and density
14. Lung volumes and forced ventilatory flows: Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: Official statement of the European Respiratory Society
15. Universal standardization for dual X-ray absorptiometry: Patient and phantom cross-calibration results
16. Standardization of HPLC measurements of pyridinium crosslinks
17. Effect of inhaled corticosteroids on bones and growth
18. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
19. Effect of inhaled formoterol and budesonide on exacerbations of asthma
20. Inhaled corticosteroid use and bone-mineral density in patients with asthma
21. Serum osteocalcin and procollagen as markers for the risk of osteoporotic fracture in corticosteroid-treated asthmatic adults
22. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone